Demecan supplies cannabis to federal government

In 2019, the startup received an order from the Federal Institute for Drugs and Medical Devices to grow medical cannabis.

Demecan has delivered medical cannabis from its own cultivation to the Federal Institute for Drugs and Medical Devices for the first time. The shipment included over 100 kilograms of dried cannabis flowers.

Since 2017, the medical use of cannabis has been approved in Germany. In the same year, Adrian Fischer, Cornelius Maurer and Constantin von der Groeben founded their start-up Demecan. In 2019, the startup became the only German company to win a contract to produce medical cannabis for pharmacies. In the summer of 2020, the start-up bought a former slaughterhouse in Saxony for this purpose and converted it into a modern cannabis plantation. A total of 2500 plants with high THC content are currently growing in the start-up's flowering rooms. So far, the company has been able to harvest 300 kilograms of cannabis flowers. The order from the Federal Institute for Drugs and Medical Devices is initially valid for four years. Up to 660 kilograms are to be delivered to the federal institute annually.

"At last, it is possible to obtain cannabis from Germany in pharmacies. I am particularly pleased that many patients can be helped with this fine product and that we can improve the supply situation in this country through cultivation," says Demecan co-founder and CEO Adrian Fischer. Because of the modular structure of the plantation, it is also possible to produce considerably more at short notice, he adds.